Skip to search formSkip to main contentSkip to account menu

DT-5461a

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

DT 5461Polysaccharides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice
We investigated the antitumor effects of a synthetic lipid A derivative, DT-5461a, in combination with indomethacin in three… 
1996
1996
Systemic administration of a synthetic lipid A derivative, DT-5461a, reduces tumor blood flow through endogenous TNF production in hepatic cancer model of VX2 carcinoma in rabbits.
Intravenous administration of DT-5461a, synthetic low-toxicity lipid A derivative, significantly inhibited the growth of VX2… 
1995
1995
DT-5461a, an antitumor synthetic lipid a analog, causes selective blood flow reduction in tumor tissue.
We previously reported that a synthetic low-toxicity lipid A analog, DT-5461a, exhibited a significant antitumor effect was… 
1995
1995
Production of tumor necrosis factor induced by synthetic low-toxicity lipid A analog, DT-5461a, is mediated by LPS receptor sites and tyrosine kinase-MAP kinase signaling pathway in murine…
1994
1994
Antitumor synthetic lipid A analog DT-5461a upregulates cytokine expression in a murine macrophage cell line through LPS pathway.
We previously showed that DT-5461a, a lipid A analog, has antitumor activity and relatively low toxicity in animals. To clarify… 
1994
1994
Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)